|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Investments, at fair value: | ||||||||||||||||||||
| Debt securities (amortized cost of $554,257 and $558,544) | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Investments in debt and equity securities, at fair value | ||||||||||||||||||||
| Receivables: | ||||||||||||||||||||
| Premiums from agencies | ||||||||||||||||||||
| Trade and other | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Notes | ||||||||||||||||||||
| Allowance for uncollectible amounts | ||||||||||||||||||||
| Total receivables | ||||||||||||||||||||
| Property and equipment: | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Buildings and improvements | ||||||||||||||||||||
| Furniture and equipment | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Property and equipment | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Title plants, at cost | ||||||||||||||||||||
| Investments in investees, on an equity method basis | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net of amortization | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Notes payable and line of credit | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Estimated title losses | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Liabilities, Total | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common Stock – $1 par, authorized 51,500,000; issued 30,575,472 and 28,115,852; outstanding 30,223,311 and 27,763,691, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Common Stock ($1 par value) and additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss: | ||||||||||||||||||||
| Foreign currency translation adjustments | ||||||||||||||||||||
| Net unrealized losses on debt securities investments | ||||||||||||||||||||
| Treasury stock – 352,161 common shares, at cost | ||||||||||||||||||||
| Stockholders’ equity attributable to Stewart | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders’ equity ($30,449,652 and 30,223,311 shares outstanding) | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
